APA (7th ed.) Citation

V, K., ZA, Y., P, D., EH, H., E, M., R, B., . . . TF, B. (2024). TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer. Oncogene, 43(19), 1431. https://doi.org/10.1038/s41388-024-02987-5

Chicago Style (17th ed.) Citation

V, Kumar, et al. "TWIST1 Is a Critical Downstream Target of the HGF/MET Pathway and Is Required for MET Driven Acquired Resistance in Oncogene Driven Lung Cancer." Oncogene 43, no. 19 (2024): 1431. https://doi.org/10.1038/s41388-024-02987-5.

MLA (9th ed.) Citation

V, Kumar, et al. "TWIST1 Is a Critical Downstream Target of the HGF/MET Pathway and Is Required for MET Driven Acquired Resistance in Oncogene Driven Lung Cancer." Oncogene, vol. 43, no. 19, 2024, p. 1431, https://doi.org/10.1038/s41388-024-02987-5.